Literature DB >> 2418582

Epitope mapping of the outer structural protein VP1 of three different serotypes of foot-and-mouth disease virus.

R H Meloen, S J Barteling.   

Abstract

All overlapping hexapeptides of the outer structural protein VP1 of type O1, type A10, and type C1 were reacted with the appropriate anti-virus, anti-viral subunit and anti-VP1 sera. The results suggest that anti-virus sera may contain activities against viral subunit and VP1 as well as against virus. Furthermore the antigenic peptides associated with the intact virion of all three serotypes are found at similar locations on their respective VP1s, and produced neutralizing activities when used for vaccination. The results further offer an explanation for the often observed cross-reactions between serotypes, especially at the level of the viral subunit and VP1. The reliability of predictions of useful peptides from hydrophilicity profiles and secondary structure predictions is questioned. Predictions based on variation profiles appear to be more useful.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2418582     DOI: 10.1016/0042-6822(86)90086-3

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  6 in total

1.  Antibodies that neutralize human beta interferon biologic activity recognize a linear epitope: analysis by synthetic peptide mapping.

Authors:  P N Redlich; P D Hoeprich; C B Colby; S E Grossberg
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

2.  Characterization of monoclonal antibodies against a type SAT 2 foot-and-mouth disease virus.

Authors:  J R Crowther; C A Rowe; R Butcher
Journal:  Epidemiol Infect       Date:  1993-10       Impact factor: 2.451

3.  Epitope mapping of the Sta58 major outer membrane protein of Rickettsia tsutsugamushi.

Authors:  R Lachumanan; S Devi; Y M Cheong; S J Rodda; T Pang
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

4.  Analysis of neutralizing antigenic sites on the surface of type A12 foot-and-mouth disease virus.

Authors:  B Baxt; V Vakharia; D M Moore; A J Franke; D O Morgan
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

5.  Proliferative lymphocyte responses to foot-and-mouth disease virus and three FMDV peptides after vaccination or immunization with these peptides in cattle.

Authors:  M J van Lierop; K van Maanen; R H Meloen; V P Rutten; M A de Jong; E J Hensen
Journal:  Immunology       Date:  1992-03       Impact factor: 7.397

6.  Basic aspects of immunomodulation through active immunization.

Authors:  R H Meloen
Journal:        Date:  2000-03-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.